Ethyl formate → 5-Chloro-3,6-dimethoxy-pyridazine-4-carbaldehyde

HRID 970357

반응식

HRID 970357 반응식
C([Li])CCC.CC1CCCN(C)C1(C)C.[Cl:16][C:17]1[CH:22]=[C:21]([O:23][CH3:24])[N:20]=[N:19][C:18]=1[O:25][CH3:26].[CH:27](OCC)=[O:28].[NH4+].[Cl-]>C1COCC1>[Cl:16][C:17]1[C:22]([CH:27]=[O:28])=[C:21]([O:23][CH3:24])[N:20]=[N:19][C:18]=1[O:25][CH3:26]

참가 물질

7

반응 조건

온도
0 °C

실험 절차

A solution of n-butyllithium (1.6 M in hexanes, 0.39 mL, 0.63 mmol) was added to a cold solution of THF (10 mL) at −78° C. Tetramethylpiperidine (0.11 L, 0.63 mmol) was introduced and the solution was warmed to 0° C. and kept at this temperature for 20 min; it is then cooled to −78° C. A solution of 4-chloro-3,6-dimethoxy-pyridazine (100 mg, 0.57 mmol) in 20 THF (5 mL) was added slowly and the mixture was stirred at −78° C. After stirring for 45 min at −78° C., ethyl formate (0.07 mL, 0.86 mmol) was added and stirring was continued at −78° C. for 15 min. Saturated aqueous NH4Cl was added and the mixture was warmed to room temperature. The mixture was extracted with EtOAc, dried over MgSO4, and concentrated in vacuo to give the crude product, which was purified by flash chromatography, eluting with 20-30% EtOAc in hexanes to afford, after evaporation, the title compound as a light yellow solid (51 mg, 44%): IR (KBr, cm−1) 1702, 1474, 1388, 1022; 1H NMR (400 MHz, DMSO) δ 10.36 (s, 1H), 4.17 (s, 3H), 4.16 (s, 3H); LCMS (+ESI, M+H+) m/z 203.

후처리

  1. temperatureit is then cooled to −78° C
  2. stirringAfter stirring for 45 min at −78° C.
  3. stirringstirring
  4. waitwas continued at −78° C. for 15 min
  5. temperaturethe mixture was warmed to room temperature
  6. extractionThe mixture was extracted with EtOAc
  7. dry with materialdried over MgSO4
  8. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-a632194c2d4248fdbfc6364b2ffb914a
출처 데이터셋
uspto-grants-2007_12
특허 번호
US07312215B2

연결된 노트

불러오는 중…